Ken‐ichi Tabata

2.8k total citations
137 papers, 2.0k citations indexed

About

Ken‐ichi Tabata is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ken‐ichi Tabata has authored 137 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 24 papers in Surgery. Recurrent topics in Ken‐ichi Tabata's work include Prostate Cancer Treatment and Research (52 papers), Prostate Cancer Diagnosis and Treatment (34 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Ken‐ichi Tabata is often cited by papers focused on Prostate Cancer Treatment and Research (52 papers), Prostate Cancer Diagnosis and Treatment (34 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Ken‐ichi Tabata collaborates with scholars based in Japan, United States and United Kingdom. Ken‐ichi Tabata's co-authors include Norihisa Fujita, Masatsugu Iwamura, Akira Shiraishi, Takefumi Satoh, Shiro Baba, Tetsuo Fujita, Kazumasa Matsumoto, Hideyasu Tsumura, Kazushige Hayakawa and Masahiro Ito and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ken‐ichi Tabata

129 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken‐ichi Tabata Japan	25	701	566	299	296	189	137	2.0k
Cheng–Chia Wu United States	23	355 0.5×	480 0.8×	231 0.8×	101 0.3×	87 0.5×	90	2.3k
Won Jun Kang South Korea	29	568 0.8×	712 1.3×	342 1.1×	672 2.3×	78 0.4×	148	2.9k
Jillian R. Gunther United States	24	511 0.7×	392 0.7×	383 1.3×	118 0.4×	175 0.9×	123	1.8k
Dae Hyuk Moon South Korea	34	827 1.2×	744 1.3×	548 1.8×	501 1.7×	296 1.6×	169	4.0k
Mark A. Green United States	21	937 1.3×	531 0.9×	841 2.8×	144 0.5×	161 0.9×	68	2.2k
Giuseppe De Vincentis Italy	29	817 1.2×	231 0.4×	503 1.7×	227 0.8×	126 0.7×	205	2.6k
Oliver Thews Germany	34	611 0.9×	1.3k 2.3×	773 2.6×	268 0.9×	77 0.4×	135	3.9k
Boyang Jason Wu United States	23	485 0.7×	768 1.4×	306 1.0×	193 0.7×	38 0.2×	65	1.9k
Vasileios Askoxylakis Germany	25	390 0.6×	735 1.3×	754 2.5×	228 0.8×	35 0.2×	49	2.5k

Countries citing papers authored by Ken‐ichi Tabata

Since Specialization

Citations

This map shows the geographic impact of Ken‐ichi Tabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Tabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Tabata more than expected).

Fields of papers citing papers by Ken‐ichi Tabata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ichi Tabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Tabata. The network helps show where Ken‐ichi Tabata may publish in the future.

Co-authorship network of co-authors of Ken‐ichi Tabata

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Tabata. A scholar is included among the top collaborators of Ken‐ichi Tabata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Tabata. Ken‐ichi Tabata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Narita, Shintaro, Naoki Terada, Kyoko Nomura, et al.. (2022). Cancer‐specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy. International Journal of Urology. 29(10). 1147–1154.

Nagumo, Yoshiyuki, Mizuki Onozawa, Takahiro Kojima, et al.. (2022). Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden. International Journal of Urology. 29(5). 398–405. 7 indexed citations

Tsumura, Hideyasu, Takefumi Satoh, Ken‐ichi Tabata, et al.. (2022). A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer. Radiation Oncology. 17(1). 67–67. 6 indexed citations

Goh, Jeffrey C., Josep M. Piulats, Marine Gross‐Goupil, et al.. (2020). 231P Phase II study of pembrolizumab in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer (mCRPC): Updated follow-up of cohorts (C) 1-3 from KEYNOTE-199. Annals of Oncology. 31. S1331–S1332. 2 indexed citations

Tsumura, Hideyasu, Takefumi Satoh, Hiromichi Ishiyama, et al.. (2017). Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer. International Journal of Molecular Sciences. 18(1). 128–128. 26 indexed citations

Matsubara, Nobuaki, Yoko Yamada, Ken‐ichi Tabata, et al.. (2017). Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 16(2). 142–148. 29 indexed citations

Yamada, Yoko, Nobuaki Matsubara, Ken‐ichi Tabata, et al.. (2016). Abiraterone acetate after progression with enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: a multi-center retrospective analysis. BMC Research Notes. 9(1). 471–471. 16 indexed citations

Matsumoto, Kazumasa, Takahiro Hirayama, Masaomi Ikeda, et al.. (2015). Gemcitabine Plus Nedaplatin as Salvage Therapy is a Favorable Option for Patients with Progressive Metastatic Urothelial Carcinoma After Two Lines of Chemotherapy. Asian Pacific Journal of Cancer Prevention. 16(6). 2483–2487. 10 indexed citations

Matsubara, Nobuaki, Itsuhiro Takizawa, Tsutomu Nishiyama, et al.. (2015). A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer. Japanese Journal of Clinical Oncology. 45(8). 774–779. 8 indexed citations

10.

Kubo, Makoto, Takefumi Satoh, Ken‐ichi Tabata, et al.. (2015). Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy. Molecular and Clinical Oncology. 3(3). 515–521. 9 indexed citations

11.

Kato, Rie, et al.. (2013). Transversus abdominis plane block provides postoperative analgesic effects after cesarean section: Additional analgesia to epidural morphine alone. Journal of obstetrics and gynaecology research. 39(9). 1397–1405. 19 indexed citations

12.

Kurosaka, Shinji, Takefumi Satoh, Edward Chow, et al.. (2012). EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy. Annals of Nuclear Medicine. 26(6). 485–491. 15 indexed citations

13.

Ikeda, Masaomi, Tetsuo Fujita, Sumiyuki Mii, et al.. (2012). Erythema Multiforme Induced by Sorafenib for Metastatic Renal Cell Carcinoma. Japanese Journal of Clinical Oncology. 42(9). 820–824. 19 indexed citations

14.

Satoh, Takefumi, Ken‐ichi Tabata, Masaki Kimura, et al.. (2011). Prevalence of Fluoroquinolone-resistant Escherichia coli Before and Incidence of Acute Bacterial Prostatitis After Prostate Biopsy. Urology. 78(6). 1235–1239. 39 indexed citations

15.

Ikeda, M., et al.. (2011). Combination of Gemcitabine and Paclitaxel is a Favorable Option for Patients with Advanced or Metastatic Urothelial Carcinoma Previously Treated with Cisplatin-based Chemotherapy. Japanese Journal of Clinical Oncology. 41(10). 1214–1220. 18 indexed citations

16.

Satoh, Takefumi, Hiromichi Ishiyama, Kazumasa Matsumoto, et al.. (2009). Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience. Japanese Journal of Radiology. 27(9). 348–354. 3 indexed citations

17.

Satoh, Takefumi, Masaki Kimura, Kazumasa Matsumoto, et al.. (2009). Single infusion of zoledronic acid to prevent androgen deprivation therapy‐induced bone loss in men with hormone‐naive prostate carcinoma. Cancer. 115(15). 3468–3474. 34 indexed citations

18.

Satoh, Takefumi, Kazumasa Matsumoto, Tetsuo Fujita, et al.. (2005). Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology. 66(1). 114–118. 52 indexed citations

19.

Tomura, Noriaki, A Inugami, Iwao Kanno, et al.. (1990). Differentiation between Cerebral Embolism and Thrombosis on Sequential CT Scans. Journal of Computer Assisted Tomography. 14(1). 26–31. 4 indexed citations

20.

Nakajima, Tamie, et al.. (1985). Polyneuropathy caused by n-hexane used under the commercial name of "Benzine".. Sangyo Igaku. 27(5). 340–341. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact